The Unknown Role of Periostin in Psoriatic Epidermal Hyperplasia

Int J Mol Sci. 2023 Nov 14;24(22):16295. doi: 10.3390/ijms242216295.

Abstract

Psoriasis is an inflammatory skin disease that affects 1-2% of the general population. The pathomechanism is based on type 1 immunological reactions. Hyperplasia of the epidermis in psoriasis is a result of disrupted epidermal architecture due to increased synthesis and expression of extracellular matrix proteins. In our study, we analyzed the involvement of periostin (POSTN) in the pathogenesis of psoriasis, as one of the extracellular matrix proteins belonging to the fasciclin family. The study group consisted of 70 patients with psoriasis, while the control group comprised 30 healthy individuals. The serum concentrations of POSTN, Il-6, Il-17, Il-22, TNF-α and IFN-γ were measured in all participants. The severity of psoriasis was determined using the PASI (Psoriasis Area and Severity Index) score. The presence of POSTN in biopsy samples of 50 patients was assessed using the direct immunofluorescence method. The results were subjected to statistical analysis. The serum concentrations of POSTN, Il-6, Il-17, Il-22, TNF-α and IFN-γ in the study group are significantly higher than in the control group. Positive correlation has been demonstrated between the PASI score and the investigated cytokines, but not with POSTN. There was no statistically significant correlation between the POSTN level and the cytokines levels. POSTN deposits were localized in the epidermis in 66% of patients with psoriasis. The role of POSTN in the pathogenesis of psoriasis remains unclear. The mechanisms inducing the synthesis and expression of POSTN in psoriatic skin are not yet fully understood. Further research is needed to enhance our understanding of the mechanism underlying epidermal hyperplasia in psoriasis.

Keywords: epidermis; hyperplasia; pathomechanism; periostin; psoriasis.

MeSH terms

  • Cytokines / metabolism
  • Extracellular Matrix Proteins
  • Humans
  • Hyperplasia
  • Interleukin-17*
  • Interleukin-6
  • Psoriasis* / metabolism
  • Tumor Necrosis Factor-alpha

Substances

  • Interleukin-17
  • Tumor Necrosis Factor-alpha
  • Interleukin-6
  • Cytokines
  • Extracellular Matrix Proteins

Grants and funding

This study was funded by a Basic Research Activity the Nicolaus Copernicus University in Toruń Ludwik Rydygier Collegium Medicum in Bydgoszcz, Poland.